Vir Biotechnology names Aziz Sawaf as new CFO effective October 5, 2026
Theravance Biopharma's former CFO takes over Vir's finance, IT and investor relations functions as Brent Sabatini steps down from interim duties.
SEC filing
Latest
5 stories
Today
Thursday, August 13
Olema Oncology names Jason O'Byrne as chief financial officer
The appointment, effective August 11, 2026, comes as the company approaches pivotal data from its OPERA-01 trial and prepares for a potential first commercial launch.
SEC filing
Wednesday, August 5
Vir reports Week 96 SOLSTICE data, ECLIPSE program fully enrolled, VIR-5500 expansion underway
Second-quarter update details 88% viral suppression in hepatitis delta trial, Astellas collaboration progress, and $1.0 billion cash position.
SEC filing
Friday, July 24
Vir Biotechnology CFO Jason O'Byrne to depart; interim replacement named
O'Byrne will leave his post on August 3, 2026, and Chief Accounting Officer Brent Sabatini will step in as interim principal financial officer.
SEC filing